Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Caribou Biosciences (CRBU) Other Operating Expenses (2025)

Caribou Biosciences (CRBU) has disclosed Other Operating Expenses for 1 consecutive years, with $12.1 million as the latest value for Q2 2025.

  • Quarterly Other Operating Expenses changed N/A to $12.1 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $12.1 million through Dec 2025, changed N/A year-over-year, with the annual reading at $12.1 million for FY2025, N/A changed from the prior year.
  • Other Operating Expenses for Q2 2025 was $12.1 million at Caribou Biosciences.
  • The five-year high for Other Operating Expenses was $12.1 million in Q2 2025, with the low at $12.1 million in Q2 2025.